RGNX Stock Analysis: Buy, Sell, or Hold?
RGNX - REGENXBIO Inc.
$6.69
0.17 (2.61%)
▲
5d:
+0.0%
30d:
-28.75%
90d:
-26.81%
BUY
HIGH Confidence
Analysis Updated: Jun 3, 2026 12:00 AM ET
Earnings: Aug 06, 2026
Get Alerted When RGNX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: RGNX shows strong fundamentals and good volume confirmation. Solid entry point despite slightly low pricing.
✅ BUY SIGNAL: RGNX shows strong fundamentals and good volume confirmation. Solid entry point despite slightly low pricing.
In-depth Analysis How we analyze
Valuation Analysis: RGNX is currently trading at $6.69, which is considered slightly low relative to its 30-day fair value range of $6.23 to $9.59.
Technical Outlook: Technically, RGNX is in a downtrend. Immediate support is located at $5.57, while resistance sits at $7.32.
Market Sentiment: The stock shows a mixed technical setup (45/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $24.18 (+261.5%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, RGNX is in a downtrend. Immediate support is located at $5.57, while resistance sits at $7.32.
Market Sentiment: The stock shows a mixed technical setup (45/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $24.18 (+261.5%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Historical Trading Range
$6.23 -
$9.59
Company Quality Score
53/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
82.6%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (45/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 261.5% below Wall St target ($24.18)
Trading Range Analysis
30-Day Trading Range
$6.23 -
$9.59
Current vs Trading Range
SLIGHTLY LOW
Support & Resistance Levels
Support Level
$5.57
Resistance Level
$7.32
Current Trend
Downtrend
Technical data as of
Jun 3, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-2.65
Wall Street Target
$24.18
(+261.5%)
Revenue Growth (YoY)
-92.8%
Share & Embed Analysis
Last updated: June 03, 2026 7:04 PM ET
Data refreshes hourly during market hours. Next update: 8:04 PM
Data refreshes hourly during market hours. Next update: 8:04 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is RGNX showing a specific setup today?
Insider Activity (6 Months)
0
Buys
1
Sells
Net
INSIDERS SELLING
Recent Transactions
Steve Pakola
SELL
5124 shares
2026-03-10
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BMRN
Biomarin Pharmaceutical … |
STRONG BUY
29 analysts |
$88 | 59 HOLD |
|
IONS
Ionis Pharmaceuticals Inc |
BUY
26 analysts |
$101 | 60 HOLD |
|
CYTK
Cytokinetics Inc |
STRONG BUY
21 analysts |
$105 | 59 HOLD |
|
BHVN
Biohaven Ltd. |
STRONG BUY
16 analysts |
$22 | 55 HOLD |
|
RVMD
Revolution Medicines Inc |
STRONG BUY
12 analysts |
$183 | 62 BUY |
